We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Most of the cancer tissues displayed moderate dot-like nuclear staining with additional cytoplasmic positivity in a few cases. Strong staining was observed in several ovarian and rare urothelial cancers.
Most cancers displayed weak to moderate nuclear positivity. Rare ovarian, skin cancers and melanoma showed strong positivity. Renal, liver, breast and colorectal cancers were weakly stained or negative.
Most cancer tissues showed weak to moderate nuclear and cytoplasmic positivity. Renal cell carcinomas along with several lymphomas, endometrial, prostate, liver and breast cancers were negative.
GENE INFORMATION
Gene name
TAB1 (HGNC Symbol)
Synonyms
MAP3K7IP1
Description
TGF-beta activated kinase 1/MAP3K7 binding protein 1 (HGNC Symbol)
Entrez gene summary
The protein encoded by this gene was identified as a regulator of the MAP kinase kinase kinase MAP3K7/TAK1, which is known to mediate various intracellular signaling pathways, such as those induced by TGF beta, interleukin 1, and WNT-1. This protein interacts and thus activates TAK1 kinase. It has been shown that the C-terminal portion of this protein is sufficient for binding and activation of TAK1, while a portion of the N-terminus acts as a dominant-negative inhibitor of TGF beta, suggesting that this protein may function as a mediator between TGF beta receptors and TAK1. This protein can also interact with and activate the mitogen-activated protein kinase 14 (MAPK14/p38alpha), and thus represents an alternative activation pathway, in addition to the MAPKK pathways, which contributes to the biological responses of MAPK14 to various stimuli. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]